Politician(s) lobbied:Billy Kelleher (MEP), European Parliament
Intent: A letter was drafted to inform the MEP about the non-pharmacovigilance procedure.
Methods:Email
Details by Method
Email
DLA Piper emailed the office of MEP Kelleher to set up a meeting with its client, Currax Pharmaceuticals LLC, concerning the non-pharmacovigilance procedure at the EU level. Due to conflicting schedules, the meeting did not take place. DLA Piper subsequently emailed the office of MEP Kelleher to inform him of Currax Pharmaceuticals LLC’s position regarding the procedure.